Julien M Buyck Selected Research

RX-P873

8/2015

RX-P873, a Novel Protein Synthesis Inhibitor, Accumulates in Human THP-1 Monocytes and Is Active against Intracellular Infections by Gram-Positive (Staphylococcus aureus) and Gram-Negative (Pseudomonas aeruginosa) Bacteria.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Julien M Buyck Research Topics

Disease

5	Infections 10/2016 - 08/2012
2	Pseudomonas Infections 10/2016 - 01/2015
2	Cystic Fibrosis (Mucoviscidosis) 08/2012 - 03/2012
1	Candidemia 03/2024
1	Hemolysis 11/2021
1	Necrosis 01/2017

Drug/Important Bio-Agent (IBA)

2	Anti-Bacterial Agents (Antibiotics)IBA 01/2015 - 05/2013
1	EchinocandinsIBA 03/2024
1	Colistin (Coly-Mycin)FDA Link 11/2021
1	geraniol (nerol)IBA 11/2021
1	FarnesolIBA 11/2021
1	InflammasomesIBA 01/2017
1	Interleukin-17 (Interleukin 17)IBA 10/2016
1	Type III Secretion SystemsIBA 10/2015
1	RX-P873IBA 08/2015
1	Protein Synthesis InhibitorsIBA 08/2015
1	Azithromycin (Zithromax)FDA LinkGeneric 08/2012
1	MacrolidesIBA 08/2012
1	temocillinIBA 03/2012

Therapy/Procedure

1	Therapeutics 10/2016